Warning: Undefined array key "file" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Vorinostat CAS 149647-78-9

High Quality Antineoplastic Drugs Chemical Powder Vorinostat CAS 149647-78-9

 

  • Ainm toraidh:

    Vorinostat CAS 149647-78-9

  • Ìre:

    Pharmaceutical grade/Cosmetic grade

  • Feartan:

    fùdar geal

  • Pacadh:

    25kg / druma

  • MOQ:

    1 kilo

  • Stòradh:Àite tioram fionnar
  • Beatha sgeilp:2 bhliadhna


Mion-fhiosrachadh

Tagaichean

Tuairisgeul toraidh

Vorinostat is a potent HDAC inhibitor with significant applications in cancer treatment, regulating gene expression, and potentially antiviral activities.

  1. HDAC Inhibition: Vorinostat functions by specifically binding to and inhibiting HDAC, including HDAC1, HDAC2, HDAC3 (Class I), and HDAC6 (Class II), thereby altering the acetylation status of histones and other proteins.
  2. Gene Expression Regulation: By inhibiting HDAC activity, Vorinostat helps to restore normal gene expression patterns, which are often disrupted in cancer cells. This leads to cell cycle arrest and apoptosis (programmed cell death) in cancer cells.
  3. Antiviral Activity: Studies have also shown that Vorinostat has the potential to reactivate latent HIV virus in patients, although further research is needed to fully understand and exploit this antiviral property in clinical settings.

 

 

Iarrtas
  1. Anticancer Drug: Vorinostat is primarily utilized as an anticancer agent, particularly in the treatment of cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin's lymphoma that has worsened, persisted, or recurred after two systemic therapies.
  2. FDA Approval: It was approved by the U.S. Food and Drug Administration (FDA) in October 2006 for the treatment of skin cancer, marking it as the first FDA-approved drug for metastatic CTCL when other therapies have failed, the disease has worsened, or has returned.
  3. Combination Therapy: Vorinostat can also be used in combination with other antitumor drugs to enhance their synergistic effects.

 

Buannachdan

Tha mòran fhactaraidhean àrd-inbhe againn le co-obrachadh domhainn, a bheir dhut toraidhean àrd-inbhe agus prìsean farpaiseach. Agus is urrainn dhuinn cuideachd lasachaidhean a thoirt seachad airson mòr-cheannach. Tha an ùine lìbhrigidh timcheall air 3-20 latha às deidh dearbhadh pàighidh.

 

Sònrachadh

 

Gluasad agus pàigheadh


 

Ceistean Cumanta

1. An e factaraidh no companaidh malairt a th 'annad?
Tha sinn nar companaidh a tha ag amalachadh gnìomhachas agus malairt, a’ toirt seachad seirbheis aon-stad. Dh’ fhaodadh gabhail ri OEM.

2. A bheil thu a 'toirt seachad samples? A bheil e an-asgaidh no a bharrachd?
Saor an-asgaidh samples.The shampall cìs bathair feumar pàigheadh ​​le ur taobh.

3. A bheil teisteanasan sam bith agad co-cheangailte ri smachd càileachd?
Teisteanas ISO 9001: 2008 gus dèanamh cinnteach à càileachd.

4. Dè a bu chòir dhomh a thoirt seachad gus luachan fhaighinn?
Bidh Pls ag innse dhuinn mun t-seòrsa toraidh a dh’ fheumas tu, meud òrduigh, seòladh agus riatanasan sònraichte. Thèid an luachan a dhèanamh airson do iomradh ann an ùine.

5. Dè an seòrsa dòigh pàighidh as fheàrr leat? Dè an seòrsa teirmean ris an tèid gabhail?
Cumhachan Lìbhrigeadh ris an deach gabhail: FOB, CFR, CIF, EXW;
Airgead pàighidh ris an deach gabhail: USD;
Accepted Payment Type: T/T,Western Union; Paypal,BTC
Cànan air a labhairt: Beurla.

 

Ma tha ùidh agad anns na stuthan againn, faodaidh tu roghnachadh d’ fhiosrachadh fhàgail an seo, agus bidh sinn ann an conaltradh riut a dh’ aithghearr.


Sgrìobh do theachdaireachd an seo agus cuir thugainn e